In the relentless race for innovation and revenue, pharmaceutical companies often find themselves sitting on a treasure trove of dormant assets—compounds, formulations, or patents that have lost their immediate commercial appeal but still hold signific…

The Hidden Cost of Evergreening: How Strategic Patent Tactics Are Stalling Innovation and Keeping Drugs Out of Reach
In the relentless pursuit of profit, pharmaceutical giants have mastered a strategy that’s quietly reshaping the landscape of healthcar…

In the relentless race for pharmaceutical dominance, patent strategies are evolving into complex chess matches—each move meticulously calculated to extend market exclusivity and stifle competition. The latest battleground? Chaining injunctions—a sophis…

In the complex labyrinth of pharmaceutical innovation, patent thickets have long been a formidable barrier—stifling competition, delaying access to life-saving drugs, and inflating healthcare costs. For years, industry leaders and policymakers have gra…

In the high-stakes world of pharmaceutical innovation, the race to market isn’t just about developing groundbreaking drugs—it’s also about strategically navigating the complex landscape of patent exclusivity. For generic manufacturers, the 180-day excl…

In the fiercely competitive world of pharmaceutical innovation, securing a patent for a new drug is only half the battle. The real challenge begins when navigating the complex landscape of FDA applications, especially Para-IV filings, which are pivotal…

Unlocking the Future of Biopharma: Navigating Risks and Opportunities in Generics and Biosimilars
In the rapidly evolving landscape of biopharmaceuticals, investors are often left grappling with a complex web of innovation, regulation, and market dynam…

In the high-stakes world of pharmaceutical innovation, China’s evolving patent landscape is akin to navigating a treacherous dragon’s den—full of opportunity, but fraught with peril for the unprepared. As global pharma companies race to secure market s…

In the fiercely competitive world of pharmaceutical market access, timing is everything. Yet, many teams still grapple with a critical question: Is our drug patent truly secure? The answer isn’t just a matter of legal documentation; it’s a strategic le…

In the high-stakes world of pharmaceuticals, innovation is often celebrated as the lifeblood of progress. But lurking beneath the surface of patent filings and blockbuster drugs lies a strategic, often controversial practice known as “evergreening.” It…